IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — ONMD

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.360.230.150.120.141.930.410.170.610.000.010.230.010.160.530.800.03
Accounts Receivable0.660.700.580.250.250.060.080.250.09----------------
Total Current Assets1.311.461.452.271.634.300.960.660.020.000.010.230.010.200.680.81--
Property, Plant & Equipment0.050.050.060.070.100.080.090.090.09----------------
Total Non-current Assets*0.050.050.060.070.100.080.090.0919.3129.9829.73120.13118.66117.36117.30117.30--
Total Assets1.361.511.512.341.734.391.040.7519.3329.9829.74120.37118.67117.57117.98118.110.07
Accounts Payable3.473.943.855.256.876.166.485.881.48----------------
Short-term Debt0.700.84----2.332.31----------------------
Total Current Liabilities4.735.365.016.1618.1518.6320.0514.663.082.092.341.451.170.570.020.05--
Long-term Debt0.130.18----2.332.312.39--------------------
Total Non-current Liabilities*0.160.230.440.020.130.030.181.7947.558.047.547.235.676.118.8110.20--
Total Liabilities4.885.595.456.1818.2818.6620.2316.4550.6310.139.888.696.836.688.8310.250.05
Retained Earnings(108.99)(106.82)(101.23)(100.49)(103.47)(99.20)(97.14)(93.55)(88.90)(11.72)(11.72)(8.45)(6.61)(6.41)(8.15)4.31-0.00
Total Stockholder Equity*(3.52)(4.08)(3.94)(3.84)(16.55)(14.27)(19.19)(15.70)(11.62)19.8519.86(8.45)(6.61)(6.41)(8.14)5.000.02

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021
Total Revenue0.290.100.890.180.160.140.030.140.230.250.340.33--0.20------------
Cost of Revenue0.860.480.710.400.400.360.050.230.330.320.340.29----------------
Gross Profit(0.56)(0.38)0.18(0.22)(0.24)(0.22)(0.03)(0.08)(0.10)(0.07)0.000.03----------------
Research & Development0.320.310.460.320.380.350.340.300.380.450.930.41----------------
Selling, General & Admin0.981.482.451.391.181.362.091.871.721.361.381.31----------------
Total Operating Expenses1.702.173.332.011.822.002.642.302.352.032.441.96----------------
Operating Income(2.26)(2.55)(3.14)(2.23)(2.06)(2.22)(2.66)(2.39)(2.45)(2.10)(5.30)(1.93)(0.29)(0.35)(3.38)(0.52)(0.79)(0.61)(0.10)(0.07)
Interest Expense--------------0.010.020.03(0.49)0.50----------------
Pretax Income--------------------(33.06)(0.73)0.06(0.03)(2.55)(0.05)--------
Tax Provision--------------------(0.19)0.090.060.060.110.11--------
Net Income(2.17)(2.45)(3.14)(0.74)2.98(1.90)(2.37)(2.06)(3.59)(2.11)(32.87)(0.82)(0.09)(0.09)(2.66)(0.15)0.952.201.294.31
Basic EPS(0.04)(0.04)(0.06)(0.01)0.07(0.06)(0.05)(0.07)(0.15)(0.09)(2.07)(2.87)----------------
Diluted EPS(0.04)(0.04)(0.06)(0.01)0.07(0.06)(0.05)(0.07)(0.15)(0.09)(1.27)(2.87)----------------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021
Operating Cash Flow(1.87)(1.54)(1.71)(1.56)(2.28)(1.95)(2.03)(1.90)(1.51)(1.55)(3.99)(0.15)(0.59)(0.05)(0.14)(0.35)(0.15)(0.29)0.36(0.65)
Capital Expenditures0.010.000.010.000.000.010.040.010.000.010.020.03----------------
Free Cash Flow*(1.88)(1.54)(1.72)(1.56)(2.29)(1.95)(2.06)(1.91)(1.51)(1.55)(4.01)(0.18)----------------
Investing Cash Flow0.060.35(0.05)1.11(0.67)1.920.37(2.34)-0.00(0.01)(10.87)11.100.09(0.37)(0.21)(0.88)(1.15)--0.00(117.30)
Financing Cash Flow1.940.842.200.482.93--(0.10)5.472.041.6814.67(10.95)0.500.400.151.461.15--(0.63)118.76

* Derived from reported values